No products in the cart.
Air Pharmaceuticals monitors the safety of every product throughout its life cycle. Report a suspected side effect or quality problem in minutes.
Air Pharmaceuticals (Pvt.) Ltd. maintains a pharmacovigilance system to collect, evaluate, and act on safety information about our products, in line with the DRAP Pharmacovigilance Rules and WHO guidance.
Every report is reviewed by our team, recorded, investigated where needed, and — when required — reported to the Drug Regulatory Authority of Pakistan.
You do not need to be certain that a medicine caused the problem — if in doubt, report it.
Any unwanted or unexpected reaction, whether serious or mild, known or unlisted.
When a medicine does not seem to work as expected for its approved use.
Wrong dose, wrong patient, overdose, misuse, or accidental exposure.
Any exposure to our medicines during pregnancy or while breastfeeding.
Discoloured or broken tablets, leaking bottles, unusual taste or smell, packaging or labelling defects.
Packs that look unusual, have mismatched batch details, or were bought from unauthorised sources.
Product name, strength, batch number and expiry date (printed on the pack).
What happened, when it started, and any treatment given. Include age, gender, and other medicines — no full name required.
Email support@airpharma.com.pk (subject “Adverse Event Report”) or call +92 310 7272436.
Our team acknowledges your report and may contact you for more information.
Pharmacovigilance Department
Air Pharmaceuticals (Pvt.) Ltd.
74-75A Small Industries Estate, Kasur, Punjab, Pakistan
You may also report directly to the National Pharmacovigilance Centre of the Drug Regulatory Authority of Pakistan through the DRAP website.
Email or call our pharmacovigilance team today.